Weight and pregnancy outcomes after GLP-1 use
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how a type of weight-loss medication called GLP-1 affects pregnancy and baby outcomes. It aims to learn if this medication is safe to use early in pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman
- You are 18 years old or older
- You are less than 20 weeks pregnant at your first check-up
- You can read and speak English
- You do not have type 2 diabetes
- You have not had weight-loss surgery
- You are pregnant with only one baby
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how GLP-1 receptor agonists (medicines for diabetes or weight loss) affect the results of non-surgical gum disease treatment in adults with overweight and periodontitis. If you are 18-65, have a BMI of 25 or higher, have gum disease, and have at least 20 teeth, you may be eligible. Participants will either continue their usual care or take a GLP-1 medicine, and then receive standard gum treatment.
This study tests whether a type of diabetes/weight loss medication (GLP-1 RA, given as a shot) affects milk production in breastfeeding mothers. It may help women who need this medicine while nursing.
This study tests if a GLP-1 medication (a type of diabetes drug that also helps with weight loss) can improve pregnancy outcomes in women with PCOS who are overweight. If you have PCOS, a BMI between 28 and 35, and are trying to get pregnant, this trial might be an option for you.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
This study follows people who recently stopped taking a GLP-1 medication (like Wegovy or Ozempic) to understand how weight, eating habits, and daily routines change over time. It aims to help patients and doctors know what to expect after stopping the drug.
This study looks at what happens to weight when people stop taking GLP-1 weight-loss drugs because their insurance no longer covers them. It may help if you're worried about regaining weight after losing coverage.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.